Neoplasms: all 9,610 studies

Page 95 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.

• S-3304 in Treating Patients With Advanced Solid TumorsCompletedNCT00033566Phase 1
• A Phase 1 Study of S-3304 in Patients With Solid TumorsCompletedNCT00033215Phase 1
• This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid TumorCompletedNCT00033202Phase 1
• Imiquimod in Preventing Cervical Cancer in Women With Cervical NeoplasiaCompletedNCT00031759Phase 2
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of ChildhoodCompletedNCT00030667Phase 2
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00030368Phase 1
• Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyCompletedNCT00030108Phase 1
• 2-Methoxyestradiol in Treating Patients With Advanced Solid TumorsCompletedNCT00030095Phase 1
• BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid TumorsTerminatedNCT00028561Phase 1
• A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)CompletedNCT00028353Phase 2
• Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00027898Phase 1
• Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid TumorsCompletedNCT00027677Phase 1
• Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsCompletedNCT00027638Phase 2
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney FailureCompletedNCT00026169Phase 1
• R115777 in Treating Patients With Advanced Solid TumorsCompletedNCT00025454Phase 1
• Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced MalignanciesCompletedNCT00024648Phase 1
• Carboplatin and Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00024284Phase 1
• 10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid TumorsCompletedNCT00024245Phase 1
• SU6668 in Treating Patients With Advanced Solid TumorsCompletedNCT00024206Phase 1
• Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid TumorsCompletedNCT00024141Phase 1
• PS-341 and Doxorubicin in Treating Patients With Advanced Solid TumorsCompletedNCT00023855Phase 1
• Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & LymphomasTerminatedNCT00023166Phase 1
• Phenoxodiol in Treating Patients With Refractory Solid TumorsCompletedNCT00022295Phase 1
• EMD 121974 in Treating Patients With Advanced Solid TumorsCompletedNCT00022113Phase 1
• Bortezomib in Treating Children With Advanced Solid TumorsCompletedNCT00021216Phase 1
• Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 1
• Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic CancerCompletedNCT00019656Phase 1
• Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 1
• Stereotactic Radiosurgery in Treating Patients With Brain TumorsCompletedNCT00019578Phase 1
• PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis TherapyCompletedNCT00019565Phase 1
• Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
• Vaccine Therapy in Treating Patients With Multiple MyelomaCompletedNCT00019097Phase 2
• Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasCompletedNCT00019019Phase 1
• Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal MethotrexateCompletedNCT00018967Not applicable
• KRN5500 in Treating Patients With Solid TumorsCompletedNCT00017238Phase 1
• PS-341 in Treating Patients With Metastatic Neuroendocrine TumorsCompletedNCT00017199Phase 2
• S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or GliosarcomaCompletedNCT00017147Phase 3
• Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid TumorsCompletedNCT00014378Phase 1
• Ro 31-7453 in Treating Patients With Metastatic Solid TumorsCompletedNCT00014365Phase 1
• Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid TumorsCompletedNCT00014261Phase 1
• Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesCompletedNCT00014235Not applicable
• Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic MalignanciesCompletedNCT00013533Early Phase 1
• 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid TumorsTerminatedNCT00012194Phase 1
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
• Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonCompletedNCT00010283Phase 1/2
• Combination Chemotherapy in Treating Patients With Solid TumorsStatus unknownNCT00009932Phase 1
• Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain NeoplasmStatus unknownNCT00009854Phase 1/2
• Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00009802Phase 1
• Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving AnticonvulsantsCompletedNCT00008424Phase 1
• Blood Stem Cell Transplant in Treating Patients With Hematologic CancerTerminatedNCT00008216
• Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaStatus unknownNCT00008164Phase 2
• Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00008086Phase 1
• Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid TumorsCompletedNCT00007917Phase 1
• Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00007878Phase 1
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 1
• Flavopiridol and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00006485Phase 1
• Mistletoe Lectin in Treating Patients With Refractory Advanced Solid TumorsCompletedNCT00006477Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00006465Phase 1
• UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00006464Phase 1
• Ecteinascidin 743 in Treating Children With Refractory Solid TumorsCompletedNCT00006463Phase 1
• LY293111 in Treating Patients With Advanced Solid TumorsCompletedNCT00006375Phase 1
• Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerCompletedNCT00006368Phase 1
• Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00006354Phase 1
• Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer TreatmentCompletedNCT00006348Phase 3
• Busulfan in Treating Children and Adolescents With Refractory CNS CancerCompletedNCT00006246Phase 1
• BMS-214662 in Treating Patients With Advanced Solid TumorsCompletedNCT00006242Phase 1
• SU5416 and Carboplatin to Treat Ovarian CancerCompletedNCT00006155Phase 1
• Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00006102Phase 2
• Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00006095Phase 1
• Vinorelbine in Treating Patients With Metastatic or Advanced Solid TumorsStatus unknownNCT00006088Phase 1
• CP-609,754 in Treating Patients With Advanced Solid TumorsStatus unknownNCT00006085Phase 1
• SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00006000Phase 1
• SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid TumorsStatus unknownNCT00005996Phase 1
• BMS-214662 in Treating Patients With Solid TumorsCompletedNCT00005973Phase 1
• Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid TumorsCompletedNCT00005952Phase 1/2
• Oxaliplatin in Treating Children With Advanced Solid TumorsCompletedNCT00005844Phase 1
• Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid TumorCompletedNCT00005839Phase 1
• Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or LymphomaTerminatedNCT00005812Phase 2
• Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial NeoplasiaTerminatedNCT00005808Phase 1
• Bone Marrow Transplant in Treating Patients With Hematologic CancersCompletedNCT00005797Phase 2
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00005791Phase 1
• Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced CancerTerminatedNCT00005655Phase 1
• Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersCompletedNCT00005622Phase 2
• Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaCompletedNCT00005590Phase 3
• Gemcitabine in Treating Children With Refractory Solid TumorsCompletedNCT00005577Phase 1
• Prospective Study of Health in Runners and WalkersCompletedNCT00005494
• Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid TumorsCompletedNCT00005078Phase 1
• Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00005068Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT00005061Phase 1
• Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium BacteriaCompletedNCT00004988Phase 1
• Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid TumorsCompletedNCT00004979Phase 1/2
• ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00004926Phase 1
• Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00004919Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00004913Phase 1
• Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionCompletedNCT00004910Phase 1/2
• MS 209 Plus Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00004886Phase 1
• Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00004864Phase 1
• Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00004863Phase 1

← Neoplasms overview